FindTrial
Sign In

Performance of a new real-time continuous glucose monitoring system: a validation study of the Medtrum TouchCare Nano 14 CGM System

Performance of a new real-time continuous glucose monitoring system: a validation study of the Medtrum TouchCare Nano 14 CGM System - Performance of the Medtrum TouchCare Nano 14 CGM System

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50146
Enrollment
30
Registered
2020-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

None listed

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants will be selected from patients seen at the diabetes outpatient clinics of the Isala hospital, Zwolle and the University Medical Center in Groningen

Exclusion criteria

Exclusion criteria: Main exclusion criteria are the inability to understand the Dutch language and the presence of a severe or unstable medical condition.

Design outcomes

Primary

MeasureTime frame
The accuracy of both TouchCare Nano 14 CGMs compared to StatStrip Xpress® during the 14-day study period.—

Secondary

MeasureTime frame
The accuracy of both TouchCare Nano 14 CGMs compared to the FGM-FSL1-CGM and the StatStrip Xpress readings during the 14-day study period.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)